• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

US Dept of Justice to Arraign PharmacyChecker Exec on Counterfeit and Mislabeled Drugs Charges


August 18, 2015.

In a U.S. Department of Justice (DOJ) indictment handed down by a grand jury in November 2014 and unsealed on August 11, 2015, the Director of Pharmacy Policy and International Verifications for New York-based PharmacyChecker.com, Ram Kamath, PharmD, and Winnipeg-based CanadaDrugs.com are among fourteen individuals and companies charged with crimes related to the sale of $78 million worth of mislabeled and counterfeit prescription drugs, including smuggling, improper storage, falsifying customs declarations, money laundering and conspiracy.

Kamath will be arraigned in a U.S. federal court on Tuesday, August 25. The other defendants, located outside the U.S., have not yet been extradited to face the charges.

Source: PR Newswire

Related Videos